Nevcell

About Us

The IBG-NEVCELL Cellular Therapies Platform aims to produce safe and high-quality cellular therapy products for use in clinical practices in accordance with international standards.

These products are produced under appropriate conditions in GMP (Good Manufacturing Practices) laboratories, which are incorporate of IBG-NEVCELL and are regularly inspected by the TR Ministry of Health, Turkish Medicines and Medical Devices Agency (TİTCK).